SCD1 is highly expressed in a variety of human cancer tissues including breast, prostate, lung, colon, kidney, and ovarian cancer (Roongta et al. 2011; von Roemeling et al. 2013; Ran et al. 2018), and reports have shown SCD1 overexpression to function as an oncogene in various cancers and to predict poor clinical outcome (Huang et al. 2016; Wang et al. 2016; Wang et al. 2020a, b, c). The gene discussed is SCD; the disease is ovarian carcinoma.